Elastrin Therapeutics, Inc. — Form D/A

Elastrin Therapeutics, Inc. of GREENVILLE, SC, a company, filed a Form D amendment with the SEC on 2023-11-03. The offering totals $2.0M, of which $2.0M was reported sold. Industry: Biotechnology.

Offering

Filed: 2023-11-03
Form: D/A
Accession: 0001848350-23-000002
Industry: Biotechnology
Exemptions: 06b
Total offering: $2.0M
Amount sold: $2.0M
Investors: 2
Date of first sale: 2023-08-11
Security types: debt
Revenue range: Decline to Disclose
SEC file number: 021-491632

Issuer

Name: Elastrin Therapeutics, Inc.
CIK: 0001848350
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2017
Address: 200C PATEWOOD DR., GREENVILLE, SC, 29615
Phone: (864) 650-7155

Officers, directors & promoters (6)

Name	Role	Location
Naren Vyavahare	Director	Greenville, SC
Naren Vyavahare	Executive Officer	Greenville, SC
Patrick Burgermeister	Director	Emeryville, CA
Matthias Breugelmans	Director	Greenville, SC
Matthias Breugelmans	Executive Officer	Greenville, SC
Klaus-Dieter Langner	Director	Grenville, SC

Other filings by this issuer (7)

Filed	Form	Offering	Sold
2025-03-11	D/A	$500K	$500K
2024-09-12	D	$500K	$50K
2023-11-03	D	$4.8M	$4.8M
2023-09-08	D	$2.0M	$1.7M
2022-03-25	D	$10.0M	$3.6M
2022-03-25	D/A	$2.5M	$2.5M
2021-03-01	D	$2.5M	$500K

More